Ultrafiltration and Dry Weight—What Are the Cardiovascular Effects?
- 1 March 2003
- journal article
- review article
- Published by Wiley in Artificial Organs
- Vol. 27 (3), 227-229
- https://doi.org/10.1046/j.1525-1594.2003.07205.x
Abstract
Long-term prognosis in dialysis is poor compared to that in healthy control persons. A worsening of the prognosis is noted especially for patients who at initiation of dialysis have congestive heart failure, ischemic heart disease, or left ventricular dysfunction or hypertrophy. This is the main reason that cardiovascular causes are the most common for morbidity in these patients. The weight obtained when normal urine output is present is the dry weight. With reduced ability to excrete the volume by the kidneys in end-stage renal disease (ESRD), the body will retain water and the patient will gain weight. This extra weight is due to volume overload. While volume overload may induce a rise in blood pressure, if the heart is in acceptable condition, a fast removal of fluid by ultrafiltration (UF) during dialysis may instead cause hypotension. Ultrafiltration failure in peritoneal dialysis (PD) patients may lead to successive water retention and overhydration with subsequent cardiac failure, while volume overload may occur over a few days in hemodialysis (HD) patients. Anemia or even too-high hematocrit may impair cardiac function further and worsen conditions caused by wrong dry weight. Thus, during long-term and sustained volume overload, left ventricular (LV) hypertrophy will occur in an eccentric manner. A sustained overload then may lead to cell death and LV dilatation and, eventually, systolic dysfunction. Once a severe left ventricular dilatation has developed, the blood pressure may decrease during volume overload. A worsened prognosis is seen if malnutrition and low albumin levels are present. Volume overload necessitates ultrafiltration to achieve dry weight. Thereby, volume contraction contributes to exaggerated stimulation of or response to activation of the RAS and alpha-adrenergic sympathetic systems. If ultrafiltration goes beyond these compensatory mechanisms, hypotension will occur and increase the risk for hypoperfusion of vital organs. Such episodes may cause cardiac morbidity, aspiration pneumonia, vascular access closure, or neurological complications (seizures, cerebral infarction), besides a more rapid lowering of residual renal function. Preventive measures are, first, finding the right dry weight; second, minimizing interdialytic weight gain; third, optimizing the target for hemoglobin (110-120 g/l); fourth, lowering dialysate calcium (1.25 mmol/l); and fifth, eventually using higher dialysate potassium if long dialyses are performed.Keywords
This publication has 13 references indexed in Scilit:
- A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patientsAmerican Journal of Kidney Diseases, 2001
- Peritoneal Ultrafiltration for Chronic Congestive Heart Failure: Rationale, Evidence and FutureJMIR AI, 2001
- Inflammatory and Atherosclerotic Interactions in the Depleted Uremic PatientBlood Purification, 2000
- Preservation of Residual Renal Function — An Important GoalPeritoneal Dialysis International, 2000
- CAPD to improve quality of life in patients with refractory heart failure.Nephrology Dialysis Transplantation, 1998
- Peritoneal ultrafiltration and treatment-resistant heart failureNephrology Dialysis Transplantation, 1998
- Effects of increasing dialysis dose on serum albumin and mortality in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Death risk predictors among peritoneal dialysis and hemodialysis patients: A preliminary comparisonAmerican Journal of Kidney Diseases, 1995
- Clinical and echocardiographic disease in patients starting end-stage renal disease therapyKidney International, 1995
- Cardiac hypertrophy: Useful adaptation or pathologic process?American Journal Of Medicine, 1980